ArticleNPJ Parkinson's disease2026
Driving motor cortex oscillations restores plasticity and improves bradykinesia features in Parkinson's disease.
Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06297538 (Targeting the Motor Cortex in Parkinson's Disease by Gamma-transcranial Alternating Current Stimulation), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Targeting the Motor Cortex in Parkinson's Disease by Gamma-transcranial Alternating Current Stimulation: Pathophysiological and Therapeutic Implications
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In Parkinson's disease (PD), impaired plasticity of the primary motor cortex (M1) contributes to bradykinesia. Enhancing cortical γ oscillations through transcranial alternating current stimulation (tACS) restores M1 plasticity, but whether this translates into bradykinesia improvement remains unclear. We conducted a double-blind, sham-controlled study to determine whether M1 γ-tACS improves intermittent theta burst stimulation (iTBS)-induced plasticity and alleviates bradykinesia in PD. Forty participants (20 patients and 20 healthy controls - HCs) underwent two randomized sessions: iTBS-γ tACS and iTBS-sham tACS. We assessed corticospinal excitability and GABA-A-ergic-related intracortical inhibition using transcranial magnetic stimulation, and bradykinesia features through finger-tapping kinematic analysis before and 5, 15, and 30 min after iTBS-tACS. iTBS-sham tACS failed to induce M1 plasticity in PD, whereas iTBS-γ tACS elicited M1 plasticity (p = 0.006) and improved SICI (p = 0.004). These neurophysiological changes in PD were paralleled by improvement in bradykinesia features, i.e., faster and wider movements (all ps < 0.001). No changes were observed following iTBS-sham tACS or in HCs. SICI γ-tACS-induced changes correlated with the clinical score in patients (r = 0.68, p < 0.001), and plasticity changes correlated with velocity improvement (r = 0.61, p = 0.003). γ entrainment restores M1 plasticity and GABA-A activity, alleviating bradykinesia in PD with effects persisting beyond stimulation. These findings have translational relevance and offer insights into bradykinesia pathophysiology (ClinicalTrials.gov Identifier: NCT06297538, registration date March 7, 2024).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.